Annual Cash & Cash Equivalents
$523.02 M
-$45.17 M-7.95%
December 31, 2023
Summary
- As of February 7, 2025, SKIN annual cash & cash equivalents is $523.02 million, with the most recent change of -$45.17 million (-7.95%) on December 31, 2023.
- During the last 3 years, SKIN annual cash & cash equivalents has risen by +$513.54 million (+5413.65%).
- SKIN annual cash & cash equivalents is now -42.01% below its all-time high of $901.89 million, reached on December 31, 2021.
Performance
SKIN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$358.89 M
+$9.35 M+2.67%
September 30, 2024
Summary
- As of February 7, 2025, SKIN quarterly cash and cash equivalents is $358.89 million, with the most recent change of +$9.35 million (+2.67%) on September 30, 2024.
- Over the past year, SKIN quarterly cash and cash equivalents has dropped by -$200.55 million (-35.85%).
- SKIN quarterly cash and cash equivalents is now -60.21% below its all-time high of $901.89 million, reached on December 31, 2021.
Performance
SKIN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SKIN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.0% | -35.9% |
| 3 y3 years | +5413.6% | -34.7% |
| 5 y5 years | - | - |
SKIN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.0% | at low | -60.2% | +2.7% |
| 5 y | 5-year | -42.0% | +7057.9% | -60.2% | +3683.4% |
| alltime | all time | -42.0% | +7057.9% | -60.2% | +3683.4% |
Beauty Health Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $358.89 M(+2.7%) |
| Jun 2024 | - | $349.54 M(-21.4%) |
| Mar 2024 | - | $444.63 M(-15.0%) |
| Dec 2023 | $523.02 M(-8.0%) | $523.02 M(-6.5%) |
| Sep 2023 | - | $559.44 M(+1.8%) |
| Jun 2023 | - | $549.73 M(+3.3%) |
| Mar 2023 | - | $532.28 M(-6.3%) |
| Dec 2022 | $568.20 M | $568.20 M(-17.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $684.21 M(-16.7%) |
| Jun 2022 | - | $820.97 M(-4.5%) |
| Mar 2022 | - | $859.24 M(-4.7%) |
| Dec 2021 | $901.89 M(+9407.5%) | $901.89 M(+25.5%) |
| Sep 2021 | - | $718.62 M(+608.2%) |
| Jun 2021 | - | $101.47 M(+618.9%) |
| Mar 2021 | - | $14.12 M(+48.8%) |
| Dec 2020 | $9.49 M(+29.8%) | $9.49 M |
| Dec 2019 | $7.31 M | - |
FAQ
- What is Beauty Health annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Beauty Health?
- What is Beauty Health annual cash & cash equivalents year-on-year change?
- What is Beauty Health quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Beauty Health?
- What is Beauty Health quarterly cash and cash equivalents year-on-year change?
What is Beauty Health annual cash & cash equivalents?
The current annual cash & cash equivalents of SKIN is $523.02 M
What is the all time high annual cash & cash equivalents for Beauty Health?
Beauty Health all-time high annual cash & cash equivalents is $901.89 M
What is Beauty Health annual cash & cash equivalents year-on-year change?
Over the past year, SKIN annual cash & cash equivalents has changed by -$45.17 M (-7.95%)
What is Beauty Health quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SKIN is $358.89 M
What is the all time high quarterly cash and cash equivalents for Beauty Health?
Beauty Health all-time high quarterly cash and cash equivalents is $901.89 M
What is Beauty Health quarterly cash and cash equivalents year-on-year change?
Over the past year, SKIN quarterly cash and cash equivalents has changed by -$200.55 M (-35.85%)